161 related articles for article (PubMed ID: 29734385)
1. Growth patterns of survivors of retinoblastoma treated with ophthalmic artery chemosurgery.
Akella SS; Francis JH; Knezevic A; Ostrovnaya I; Gobin YP; Friedman D; Guarini E; Eibeler L; Catalanotti F; Abramson DH
PLoS One; 2018; 13(5):e0197052. PubMed ID: 29734385
[TBL] [Abstract][Full Text] [Related]
2. Intra-Arterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma.
Abramson DH; Daniels AB; Marr BP; Francis JH; Brodie SE; Dunkel IJ; Gobin YP
PLoS One; 2016; 11(1):e0146582. PubMed ID: 26756643
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and toxicity of second-course ophthalmic artery chemosurgery for retinoblastoma.
Francis JH; Abramson DH; Gobin YP; Marr BP; Tendler I; Brodie SE; Dunkel IJ
Ophthalmology; 2015 May; 122(5):1016-22. PubMed ID: 25616769
[TBL] [Abstract][Full Text] [Related]
4. Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma.
Abramson DH; Fabius AW; Francis JH; Marr BP; Dunkel IJ; Brodie SE; Escuder A; Gobin YP
Ophthalmic Genet; 2017; 38(1):16-21. PubMed ID: 28095092
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous Bilateral Ophthalmic Artery Chemosurgery for Bilateral Retinoblastoma (Tandem Therapy).
Abramson DH; Marr BP; Francis JH; Dunkel IJ; Fabius AW; Brodie SE; Mondesire-Crump I; Gobin YP
PLoS One; 2016; 11(6):e0156806. PubMed ID: 27258771
[TBL] [Abstract][Full Text] [Related]
6. Retinoblastoma Vitreous Seed Clouds (Class 3): A Comparison of Treatment with Ophthalmic Artery Chemosurgery with or without Intravitreous and Periocular Chemotherapy.
Francis JH; Iyer S; Gobin YP; Brodie SE; Abramson DH
Ophthalmology; 2017 Oct; 124(10):1548-1555. PubMed ID: 28545735
[TBL] [Abstract][Full Text] [Related]
7. Current Treatment of Bilateral Retinoblastoma: The Impact of Intraarterial and Intravitreous Chemotherapy.
Francis JH; Roosipu N; Levin AM; Brodie SE; Dunkel IJ; Gobin YP; Abramson DH
Neoplasia; 2018 Aug; 20(8):757-763. PubMed ID: 29940303
[TBL] [Abstract][Full Text] [Related]
8. Ophthalmic artery chemosurgery for retinoblastoma prevents new intraocular tumors.
Abramson DH; Francis JH; Dunkel IJ; Marr BP; Brodie SE; Gobin YP
Ophthalmology; 2013 Mar; 120(3):560-565. PubMed ID: 23177361
[TBL] [Abstract][Full Text] [Related]
9. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
[TBL] [Abstract][Full Text] [Related]
10. Biochemical measures of ovarian function in female survivors of retinoblastoma treated with intra-arterial melphalan: an initial report.
Marathe PH; Dunkel IJ; Francis JH; Antal Z; Gobin YP; Abramson DH; Friedman DN
Ophthalmic Genet; 2022 Dec; 43(6):806-808. PubMed ID: 36695494
[TBL] [Abstract][Full Text] [Related]
11. Second primary malignancies in retinoblastoma patients treated with intra-arterial chemotherapy: the first 10 years.
Habib LA; Francis JH; Fabius AW; Gobin PY; Dunkel IJ; Abramson DH
Br J Ophthalmol; 2018 Feb; 102(2):272-275. PubMed ID: 28600304
[TBL] [Abstract][Full Text] [Related]
12. Total retinal detachments due to retinoblastoma: Outcomes following intra-arterial chemotherapy/ophthalmic artery chemosurgery.
Rowlands MA; Mondesire-Crump I; Levin A; Mauguen A; Francis JH; Dunkel IJ; Brodie SE; Gobin YP; Abramson DH
PLoS One; 2018; 13(4):e0195395. PubMed ID: 29698399
[TBL] [Abstract][Full Text] [Related]
13. Advanced Unilateral Retinoblastoma: The Impact of Ophthalmic Artery Chemosurgery on Enucleation Rate and Patient Survival at MSKCC.
Abramson DH; Fabius AW; Issa R; Francis JH; Marr BP; Dunkel IJ; Gobin YP
PLoS One; 2015; 10(12):e0145436. PubMed ID: 26709699
[TBL] [Abstract][Full Text] [Related]
14. Ophthalmic artery chemosurgery for less advanced intraocular retinoblastoma: five year review.
Abramson DH; Marr BP; Brodie SE; Dunkel I; Palioura S; Gobin YP
PLoS One; 2012; 7(4):e34120. PubMed ID: 22545080
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and results of an intraarterial chemotherapy program for the conservative treatment of retinoblastoma in Argentina.
Funes S; Sampor C; Villasante F; Fandiño A; Manzitti J; Sgroi M; Neira P; Peralta L; Lagomarsino E; Schaiquevich P; Ceciliano A; Chantada GL
Pediatr Blood Cancer; 2018 Aug; 65(8):e27086. PubMed ID: 29693791
[TBL] [Abstract][Full Text] [Related]
16. Enucleation vs Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma: A Retrospective Analysis.
Yannuzzi NA; Francis JH; Marr BP; Belinsky I; Dunkel IJ; Gobin YP; Abramson DH
JAMA Ophthalmol; 2015 Sep; 133(9):1062-6. PubMed ID: 26181236
[TBL] [Abstract][Full Text] [Related]
17. Carboplatin +/- topotecan ophthalmic artery chemosurgery for intraocular retinoblastoma.
Francis JH; Gobin YP; Dunkel IJ; Marr BP; Brodie SE; Jonna G; Abramson DH
PLoS One; 2013; 8(8):e72441. PubMed ID: 23991112
[TBL] [Abstract][Full Text] [Related]
18. Ten-year experience with ophthalmic artery chemosurgery: Ocular and recurrence-free survival.
Francis JH; Levin AM; Zabor EC; Gobin YP; Abramson DH
PLoS One; 2018; 13(5):e0197081. PubMed ID: 29791475
[TBL] [Abstract][Full Text] [Related]
19. Retinal reattachment and ERG recovery after ophthalmic artery chemosurgery for advanced retinoblastoma in eyes with minimal baseline retinal function.
Abdelhakim AH; Francis JH; Marr BP; Gobin YP; Abramson DH; Brodie SE
Br J Ophthalmol; 2017 May; 101(5):623-628. PubMed ID: 27539090
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma.
Muen WJ; Kingston JE; Robertson F; Brew S; Sagoo MS; Reddy MA
Ophthalmology; 2012 Mar; 119(3):611-6. PubMed ID: 22197434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]